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R224President Barack Obama announced 
this month, as he had promised on 
his campaign trail, a lifting of the ban 
on federal funding for research on 
new human embryonic stem cells. 
The former president, George Bush, 
blocked the use of government money 
to fund research into any human 
embryonic stem cells created after 
9 August 2001. The decision forms 
part of Obama’s pledge to make his 
administration’s support for science 
to be freer from political interference. 
His decision is set to increase 
international competition to create 
potentially clinically useful and 
economically viable sources of 
human stem cells.
In the UK, researchers have been 
able to work on embryo-derived 
stem cells for some time, but one 
of the problems has been a lack 
of supply. More recently, and more 
controversially, the way has been 
paved to create animal–human hybrid 
embryos as a potential source of stem 
cells for researchers to overcome 
the shortage of human embryos. 
But two main groups working on 
human–animal hybrid embryos were 
recently reported by The Independent 
newspaper to be having some funding 
problems for their work.
Now, new developments have been 
reported in the use of somatic cells 
as a potential source of stem cells 
which may provide a challenge to 
embryo- derived cells and the new 
boost to such research backed by 
Obama. Two teams of researchers 
announced this month (in Nature 
online) a new way of making stem 
cells from a patient’s own cells.
Many scientists believe stem cells 
are the key to treating a number of 
conditions because of their potential 
ability to be grown into any kind 
of cell in the body. The teams of 
researchers from Britain and Canada 
have now reported a way of making 
stem cells from a patient’s skin cells. 
The research raises the prospect for 
the first time of developing stem-cell 
treatments without having to destroy 
human embryos.
Reprogramming the skin cells 
allows them to assume the properties 
of stem cells obtained from embryos.
Skin cells are claimed as a new source 
of stem cells. Nigel Williams reports.
Stem cell shifts Two teams of researchers, led by Keisuke Kaji from the Medical 
Research Council’s Centre for 
Regenerative Medicine at Edinburgh 
University and Andras Nagy from the 
University of Toronto, combined their 
research to create the stem cells that 
act like embryonic stem cells without 
the need to use viruses in the process.
Reprogramming cells using viruses, 
has been shown in earlier work, but 
the need to modify their DNA to create 
them meant that they cannot be given 
to patients without greatly increasing 
their risk of cancer.
The teams of researchers 
from Britain and Canada have 
now reported a way of making 
stem cells from a patient’s 
skin cells. The research raises 
the prospect for the first 
time of developing stem-cell 
treatments without having to 
destroy human embryos.
The new method using 
electroporation avoids the use of 
viruses and allows four genes to be 
inserted into the cell to reprogramme 
it and then be removed from the cell. 
The two teams were initially working 
separately on reprogramming but by 
chance discovered that each team 
had solved a separate part of the 
challenge, and their combined method 
appears safer and more efficient.
The researchers developed their 
techniques in both mouse and 
human skin cells and tests on the 
reprogrammed lines showed that they 
behaved exactly like embryonic stem 
cells. Nobody “thought it was really 
possible. This new method will advance 
the field of regenerative medicine, and 
should help understand diseases and 
test new drugs,” said Kaji.
“It is a step towards the practical 
use of reprogrammed cells in 
medicine, perhaps even eliminating 
the need for human embryos as a 
source of stem cells,” he said.
Human cell reprogramming was first 
achieved two years ago, but the use 
of multiple viruses to deliver the four 
crucial genes — which can reverse 
the adult cell’s fate — into the cell’s 
DNA also made them liable to switch 
on cancer-causing genes. This has previously made them unsafe for 
transplantation into patients. Before 
this new study, attempts at non-viral 
reprogramming had only succeeded 
with mouse cells, and were generally 
inefficient.
Before their collaboration, Kaji’s 
team had found a non-viral method 
to deliver the four genes in a single 
fragment. But he could not find a 
way of removing all trace of the 
reprogramming from the genome, and 
this remaining ‘footprint’ could disrupt 
other genes at the site of insertion.
Nagy’s group, however, had 
developed a reprogramming system 
that allowed the removal of inserted 
genes without a trace — but because 
their method delivered the four genes 
to different parts of the genome, they 
had not managed to remove all of 
them. The team’s breakthrough came 
when they combined their methods.
With federal funding now opening 
up in the US for embryonic stem cells, 
the race is quickening to find the best 
source of stem cells for use in the 
clinic.
Kaji said that it will be possible 
to remove not only all the inserted 
genes, but all traces of our genetic 
modification from the human 
skin- derived stem cells, “although we 
still need to improve the efficiency”.
Ian Wilmut, director of the MRC 
Edinburgh centre said it will take time 
before these stem cells can be given 
to patients. “Crucially, we need to 
have a method to generate the desired 
cell types from these stem cells. But 
I believe the team has made great 
progress and combining this work 
with that of other scientists working 
on stem-cell differentiation, there is 
hope that the promise of regenerative 
medicine could soon be met.”
US researchers, however, are 
pleased with the lifting of the federal 
ban on funds for embryo stem cell 
research. “I feel vindicated after eight 
years of struggle and I know it is 
going to energise my research team,” 
said George Daley at the Harvard 
Stem Cell Institute. The federal 
funding ban meant that researchers 
had been forced to separate any 
privately funded research from their 
government-backed projects.
“I believe that the restrictions that 
President Bush has placed on funding 
of human embryonic stem cell research 
have handcuffed our scientists and 
hindered our ability to compete with 
other nations,” Obama said.
